TargetMol

BMS-929075

Product Code:
 
TAR-T26863
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T26863-1mg1mg£223.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26863-5mg5mg£456.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26863-1mL1 mL * 10 mM (in DMSO)£551.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26863-10mg10mg£622.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26863-25mg25mg£938.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26863-50mg50mg£1,259.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26863-100mg100mg£1,669.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26863-500mg500mg£3,219.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
BMS-929075 is a HCV NS5B Replicase Palm Site Allosteric Inhibitor with high oral bioavailability and pharmacokinetic parameters. BMS-929075 exhibited a favorable cytotoxicity window.
CAS:
1217338-97-0
Formula:
C31H24F2N4O3
Molecular Weight:
538.555
Pathway:
Proteases/Proteasome|Microbiology/Virology
Purity:
0.98
SMILES:
CNC(=O)c1c(oc2ccc(c(F)c12)-c1cc(ccc1C)C(=O)NC1(CC1)c1ncccn1)-c1ccc(F)cc1
Target:
HCV Protease

References

1. Yeung KS, Beno BR, Parcella K,et al. Discovery of an HCV NS5B Replicase Palm Site Allosteric Inhibitor (BMS-929075) Advanced to Phase
1 Clinical Studies. J Med Chem. 2017 Apr 21. doi: 10.1021/acs.jmedchem.7b00328. [Epub ahead of print] PubMed PMID: 28430437.